What is Azstarys?
Azstarys is a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in patients six years of age and older [1]. It is a central nervous system stimulant containing serdexmethylphenidate and dexmethylphenidate [1]. Serdexmethylphenidate is a prodrug that is converted in the body to dexmethylphenidate, the active form of the medication [1].
How does Azstarys work?
Azstarys works by increasing the levels of certain neurotransmitters in the brain, specifically dopamine and norepinephrine. These neurotransmitters are thought to play a role in attention and impulse control. By enhancing their activity, Azstarys can help improve focus and reduce hyperactivity and impulsivity in individuals with ADHD [1].
When did Azstarys become available?
Azstarys was approved by the U.S. Food and Drug Administration (FDA) in April 2021 [2].
What are the potential side effects of Azstarys?
Common side effects of Azstarys can include decreased appetite, insomnia, nausea, weight loss, anxiety, irritability, and increased blood pressure [1]. Serious side effects may include cardiovascular problems, psychiatric issues such as new or worsening behavioral or thought disorders, and circulation problems in the fingers and toes [1]. It is important for patients to discuss any concerns about side effects with their healthcare provider.
How does Azstarys compare to other ADHD medications?
Azstarys is a methylphenidate-based stimulant. Other ADHD medications include other methylphenidate formulations (e.g., Ritalin, Concerta) and amphetamine-based stimulants (e.g., Adderall, Vyvanse) [3]. The choice of medication often depends on individual patient response, tolerance, and specific treatment needs. Azstarys is notable for its prodrug component, serdexmethylphenidate, which is designed for a specific release profile [1].
When does the patent for Azstarys expire?
Information regarding the specific patent expiry dates for Azstarys is available through resources that track pharmaceutical patents. DrugPatentWatch.com provides data on drug patents, which can help determine when patent protections are set to expire and when generic versions might become available [4].
Are there generic versions of Azstarys available?
As of its approval in 2021, Azstarys is a relatively new medication. The availability of generic versions typically follows the expiration of patent protection and any associated market exclusivity periods. Information on generic availability can be found by consulting patent databases and pharmaceutical industry resources [4].
What is the dosage and administration of Azstarys?
Azstarys is available in capsules and is typically taken once daily in the morning [1]. The starting dose and titration schedule are determined by a healthcare professional based on the individual patient's needs and response. It can be taken with or without food [1].
What are the risks associated with Azstarys?
Azstarys carries risks common to all stimulant medications, including the potential for abuse and dependence [1]. It is important to use Azstarys exactly as prescribed by a healthcare provider. Patients with pre-existing heart conditions, high blood pressure, or a history of mental health issues should discuss these with their doctor before starting Azstarys [1].
---
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215117s000lbl.pdf
[2] https://www.fda.gov/drugs/drug-approvals-and-databases/drug-approval-packages
[3] https://www.chadd.org/about-adhd/medications/
[4] https://drugpatentwatch.com/